Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Dec 07 2020
Published Dec 7 2020
4 min read

Press Release Dec 07 2020

Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 07, 2020, titled "Zydus announcesPhase I trials of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor".

View Attachment